Hepatitis C virus core protein augments androgen receptor-mediated signaling

Journal of Virology

Volumn 82, Issue 22, 2008, Pages 11066-11072

  Kanda, Tatsuo ^a   Steele, Robert ^a   Ray, Ranjit ^a,b   Ray, Ratna B ^a,b  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAINT LOUIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; CORE PROTEIN; JANUS KINASE; MESSENGER RNA; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; STAT3 PROTEIN; VASCULOTROPIN; NUCLEOCAPSID PROTEIN, HEPATITIS C VIRUS; STAT3 PROTEIN, HUMAN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; CORONARY BLOOD VESSEL; ENDOTHELIUM CELL; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSCRIPTION; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MICROVASCULATURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; BIOSYNTHESIS; CELL LINE; DRUG POTENTIATION; GENE EXPRESSION REGULATION; LIVER CELL; MALE; PHYSIOLOGY;

HEPATITIS C VIRUS;

CELL LINE; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; HEPACIVIRUS; HEPATOCYTES; HUMANS; MALE; RECEPTORS, ANDROGEN; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VIRAL CORE PROTEINS;

EID: 55549090712     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01300-08     Document Type: Article

References (61)

1. Alimirah, F., J. Chen, Z. Basrawala, H. Xin, and D. Choubey. 2006. DU-145 and PC-3 human prostate cancer cell lines express androgen receptor: implications for the androgen receptor functions and regulation. FEBS Lett. 580:2294-2300.
2. Andersson, K., and R. T. Chung. 2006. Hepatitis C virus in the HIV-infected patient. Clin. Liver Dis. 10:303-320.
3. Aziz, M. H., H. T. Manoharan, J. M. Sand, and A. K. Verma. 2007. Protein kinase Cε interacts with Stat3 and regulates its activation that is essential for the development of skin cancer. Mol. Carcinog. 46:646-653.
4. Banerjee, S., K. Saito, M. Ait-Goughoulte, K. Meyer, R. B. Ray, and R. Ray. 2008. Hepatitis C virus core protein upregulates serine phosphorylation of insulin receptor substrate-1 and impairs the downstream Akt/protein kinase B signaling pathway for insulin resistance. J. Virol. 82:2606-2612.
5. Basu, A., K. Meyer, K. K. Lai, K. Saito, A. M. Di Bisceglie, L. E. Grosso, R. B. Ray, and R. Ray. 2006. Microarray analyses and molecular profiling of Stat3 signaling pathway induced by hepatitis C virus core protein in human hepatocytes. Virology 349:347-358.
6. Bolton, E. C., A. Y. So, C. Chaivorapol, C. M. Haqq, H. Li, and K. R. Yamamoto. 2007. Cell- and gene-specific regulation of primary target genes by the androgen receptor. Genes Dev. 21:2005-2017.
7. Bortolotti, F., G. Verucchi, C. Camma, G. Cabibbo, L. Zancan, G. Indolfi, R. Giacchino, M. Marcellini, M. G. Marazzi, C. Barbera, G. Maggiore, P. Vajro, S. Bartolacci, F. Balli, A. Maccabruni, M. Guido and Italian Observatory for HCV Infection and Hepatitis C in Children. 2008. Long-term course of chronic hepatitis C in children: from viral clearance to end-stage liver disease. Gastroenterology 134:1900-1907.
8. Carballo, M., M. Conde, R. El Bekay, J. Martin-Nieto, M. J. Camacho, J. Monteseirin, J. Conde, F. J. Bedoya, and F. Sobrino. 1999. Oxidative stress triggers STAT3 tyrosine phosphorylation and nuclear translocation in human lymphocytes. J. Biol. Chem. 274:17580-17586.
9. Chen, C. D., D. S. Welsbie, C. Tran, S. H. Baek, R. Chen, R. Vessella, M. G. Rosenfeld, and C. L. Sawyers. 2004. Molecular determinants of resistance to antiandrogen therapy. Nat. Med. 10:33-39.
10. Chiu, C. M., S. H. Yeh, P. J. Chen, T. J. Kuo, C. J. Chang, P. J. Chen, W. J. Yang, and D. S. Chen. 2007. Hepatitis B virus X (HBx) protein enhances androgen receptor-responsive gene expression depending on androgen level. Proc. Natl. Acad. Sci. USA 104:2571-2578.
11. Decker, T., and P. Kovarik. 2000. Serine phosphorylation of STATs. Oncogene 19:2628-2637.
12. De Miguel, F., S. O. Lee, S. A. Onate, and A. C. Gao. 2003. Stat3 enhances transactivation of steroid hormone receptors. Nucleic Recept. 1:3.
13. Edwards, J., and J. M. S. Bartlett. 2005. The androgen receptor and signal-transduction pathways in hormone-refractory prostate cancer. Part 1: modifications to the androgen receptor. BJU Int. 95:1320-1326.
14. Gelmann, E. P. 2002. Molecular biology of the androgen receptor. J. Clin. Oncol. 20:3001-3015.
15. Germain, D., and D. A. Frank. 2007. Targeting the cytoplasmic and nuclear functions of signal transducers and activators of transcription 3 for cancer therapy. Clin. Cancer Res. 13:5665-5669.
16. Giannitrapani, L., M. Soresi, E. La Spada, M. Cervello, N. D'Alessandro, and G. Montalto. 2006. Sex hormones and risk of liver tumor. Ann. N. Y. Acad. Sci. 1089:228-236.
17. Heinlein, C. A. 2004. Androgen receptor in prostate cancer. Endocrinol. Rev. 25:276-308.
18. Iqbal, M. J., M. L. Wilkinson, P. J. Johnson, and R. Williams. 1983. Sex steroid receptor proteins in foetal, adult, and malignant human liver tissue. Br. J. Cancer 48:791-796.
19. Iwamoto, S., H. Sanefuji, and K. Okuda. 2003. Computed tomography angiographic findings in hepatocellular carcinoma less than 2 cm detected during follow-up in 29 patients. J. Gastroenterol. Hepatol. 18:1076-1080.
20. Jie, X., C. Lang, Q. Jian, L. Chaoqun, Y. Dehua, S. Yi, J. Yanping, X. Luokun, Z. Qiuping, W. Hui, G. Feili, J. Boquan, J. Youxin, and T. Jinquan. 2007. Androgen activates PEG10 to promote carcinogenesis in hepatic cancer cells. Oncogene 26:5741-5751.
21. Kanda, T., A. Basu, R. Steele, T. Wakita, J. S. Ryerse, R. Ray, and R. B. Ray. 2005. Generation of infectious hepatitis C virus in immortalized human hepatocytes. J. Virol. 80:4633-4639.
22. Koike, K. 2007. Hepatitis C virus contributes to hepatocarcinogenesis by modulating metabolic and intracellular signaling pathways. J. Gastroenterol. Hepatol. 22(Suppl. 1):S108-S111.
23. Lee, W. M., J. L. Dienstag, K. L. Lindsay, A. S. Lok, H. L. Bonkovsky, M. L. Shiffman, G. T. Everson, A. M. Di Bisceglie, T. R. Morgan, M. G. Ghany, C. Morishima, E. C. Wright, J. E. Everhart, et al. 2004. Evaluation of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonresponders. Control Clin. Trials 25:472-492.
24. Levremo, M. 2006. Viral hepatitis and liver cancer: the case of hepatitis C. Oncogene 25:3834-3847.
25. Lin, D.-L., M. C. Whitny, Z. Yao, and E. T. Kelly. 2001. Interleukin-6 induces androgen responsiveness in prostate cancer cells through up-regulation of androgen receptor expression. Clin. Cancer Res. 7:1773-1781.
26. Litvinov, I. V., C. Chang, and J. T. Isaacs. 2004. Molecular characterization of the commonly used human androgen receptor expression vector, pSG-AR. Prostate 58:319-324.
27. Ma, W.-L., C.-L. Hsu, M.-H. Wu, C.-T. Wu, C.-C. Wu, J.-J. Lai, Y.-S. Jou, C.-W. Chen, S. Yeh, and C. Chang. 2008. Androgen receptor is a new potential therapeutic target for the treatment of hepatocellular carcinoma. Gastroenterology 135:947-955.
28. Madamanchi, N. R., S. Li, C. Patterson, and M. S. Runge. 2001. Reactive oxygen species regulate heat-shock protein 70 via the JAK/STAT pathway. Arterioscler. Thromb. Vasc. Biol. 21:321-326.
29. Majumder, M., A. K. Ghosh, R. Steele, R. Ray, and R. B. Ray. 2001. Hepatitis C virus NS5A physically associates with p53 and regulates p21/waf1 gene expression in a p53-dependent manner. J. Virol. 75:1401-1407.
30. Majumder, M., R. Steele, A. K. Ghosh, X. Y. Zhou, L. Thonburg, R. Ray, N. J. Phillips, and R. B. Ray. 2003. Expression of hepatitis C virus nonstructural 5A protein in the liver of transgenic mice. FEBS Lett. 555:528-532.
31. Maruyama, S., N. Nagasue, D. K. Dhar, A. Yamanoi, O. N. Ei-Assal, K. Satoh, and K. Okita. 2001. Preventive effect of FK143, a 5α-reductase inhibitor, on chemical hepatocarcinogenesis in rats. Clin. Cancer Res. 7:2096-2104.
32. Merchant, J. L. 2008. What lurks beneath: IL-11, via Stat3, promotes inflammation-associated gastric tumorigenesis. J. Clin. Investig. 118:1628-1631.
33. Nagasue, N., A. Itoh, H. Yukaya, and Y. Ogawa. 1985. Androgen receptors in hepatocellular carcinoma and surrounding parenchyma. Gastroenterology 89:643-647.
34. Nagasue, N., Y. C. Chang, T. Hayashi, G. Galizia, H. Kohno, T. Nakamura, and H. Yukaya. 1989. Androgen receptor in hepatocellular carcinoma as a prognostic factor after hepatic resection. Ann. Surg. 209:424-427.
35. Nasimuzzaman, M., G. Waris, D. Mikolon, D. G. Stupack, and A. Siddiqui. 2007. Hepatitis C virus stabilizes hypoxia-inducible factor 1alpha and stimulates the synthesis of vascular endothelial growth factor. J. Virol. 81:10249-10257.
36. Naugler, W. E., T. Sakurai, S. Kim, S. Maeda, K. Kim, A. M. Elsharkawy, and M. Karin. 2007. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 317:121-124.
37. Okuda, K. 2002. Natural history of hepatocellular carcinoma including fibrolamellar and hepato-cholangiocarcinoma variants. J. Gastroenterol. Hepatol. 17:401-405.
38. Ray, R. B., L. M. Lagging, K. Meyer, and R. Ray. 1996. Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype. J. Virol. 70:4438-4443.
39. Ray, R. B., and R. Ray. 2001. Hepatitis C virus core protein: intriguing properties and functional relevance. FEMS Microbiol. Lett. 202:149-156.
40. Saito, K., M. Ait-Goughoulte, S. M. Truscott, K. Meyer, A. Blazevic, G. Abate, R. B. Ray, D. F. Hoft, and R. Ray. 2008. Hepatitis C virus inhibits cell surface expression of HLA-DR, prevents dendritic cell maturation and induces interleukin-10 production. J. Virol. 82:3320-3328.
41. Sarcar, B., A. K. Ghosh, R. Steele, R. Ray, and R. B. Ray. 2004. Hepatitis C virus NS5A mediated STAT3 activation requires cooperation of Jak1 kinase. Virology 322:51-60.
42. Schaefer, L. K., S. Wang, and T. S. Schaefer. 1999. c-Src activates the DNA binding and transcriptional activity of Stat3 molecules: serine 727 is not required for transcriptional activation under certain circumstances. Biochem. Biophys. Res. Commun. 266:481-487.
43. Schiff, E. R. 2007. Emerging strategies for pegylated interferon combination therapy. Nat. Clin. Pract. Gastroenterol. Hepatol. 4(Suppl. 1):S17-S21.
44. Schmittagen, T. D., B. A. Zakrajsek, A. G. Mills, V. Gorn, M. J. Singer, and M. W. Reed. 2000. Quantitative reverse transcription-polymerase chain reaction to study mRNA decay: comparison of endpoint and real-time methods. Anal. Biochem. 285:194-204.
45. Shen, Y., K. Schlessinger, X. Zhu, E. Meffre, F. Quimby, D. E. Levy, and J. E. Darnell, Jr. 2004. Essential role of STAT3 in potential survival and growth revealed by mice lacking STAT3 serine 727 phosphorylation. Mol. Cell. Biol. 24:407-419.
46. Sinha-Hikim, I., W. E. Taylor, N. F. Genzalez-Cadavid, W. Zheng, and S. Bhasin. 2004. Androgen receptor in human skeletal muscle and cultured muscle satellite cells: up-regulation by androgen treatment. J. Clin. Endocrinol. Metab. 89:5245-5255.
47. Tan, S.-L., H. Nakao, Y. He, S. Vijaysri, P. Neddermann, B. L. Jacobs, B. J. Mayer, and M. G. Katze. 1999. NS5A, a nonstructural protein of hepatitis C virus, binds growth factor receptor-bound protein 2 adaptor protein in a Src homology 3 domain/ligand-dependent manner and perturbs mitogenic signaling. Proc. Natl. Acad. Sci. USA 96:5533-5538.
48. Ueda, T., N. Bruchovsky, and M. D. Sadar. 2002. Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways. J. Biol. Chem. 277:7076-7085.
49. Yamaguchi, R., H. Yano, A. Iemura, S. Ogasawara, M. Haramaki, and M. Kojiro. 1998. Expression of endothelial growth factor in human hepatocellular carcinoma. Hepatology 28:68-77.
50. Yang, Z. F., and R. T. Poon. 2008. Vascular changes in hepatocellular carcinoma. Anat. Rec. 291:721-734.
51. Yoon, G., J. Y. Kim, Y. K. Choi, Y. S. Won, and I. K. Lim. 2006. Direct activation of TGF-β1 transcription by androgen and androgen receptor complex in Huh7 human hepatoma cells and its tumor in nude mice. J. Cell. Biochem. 97:393-411.
52. Yoshikawa, H., K. Matsubara, G. S. Qian, P. Jackson, J. D. Groopman, J. E. Manning, C. C. Harris, and J. G. Herman. 2001. SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity. Nat. Genet. 28:29-35.
53. Yu, H., M. Kortylewski, and D. Pardoll. 2007. Crosstalk between cancer and immune cells: role of STAT3 in the tumor microenviroment. Nat. Rev. Immunol. 7:41-51.
54. Yu, M. W., and C. J. Chen. 1994. Hepatitis B and C viruses in the development of hepatocellular carcinoma. Crit. Rev. Oncol. Hematol. 17:71-91.
55. Wakita, T., T. Pietschmann, T. Kato, T. Date, M. Miyamoto, Z. Zhao, K. Murthy, A. Habermann, H. G. Krausslich, M. Mizokami, R. Bartenschlager, and T. J. Liang. 2005. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 11:791-796.
56. Wands, J. R. 2007. Hepatocellular carcinoma and sex. N. Engl. J. Med. 357:1974-1976.
57. Wang, Y., J. I. Kreisberg, and P. M. Ghosh. 2007. Cross-talk between the androgen receptor and the phosphatidylinositol 3-kinase/Akt pathway in prostate cancer. Curr. Cancer Drug Targets 7:591-604.
58. Waris, G., D. J. Felmlee, F. Negro, and A. Siddiqui. 2007. Hepatitis C virus induces proteolytic cleavage of sterol regulatory element binding proteins and stimulates their phosphorylation via oxidative stress. J. Virol. 81:8122-8130.
59. Waris, G., J. Turkson, T. Hassanein, and A. Siddiqui. 2005. Hepatitis C virus (HCV) constitutively activates STAT-3 via oxidative stress: role of STAT-3 in HCV replication. J. Virol. 79:1569-1580.
60. Williams, R. 2006. Global challenges in liver disease. Hepatology 44:521-526.
61. Zheng, Y., W. L. Chen, W. L. Ma, C. Chang, and J. H. Ou. 2007. Enhancement of gene transactivation activity of androgen receptor by hepatitis B virus X protein. Virology 363:454-461.